'Blind spot': alarm sounded on weight-loss medications
Only two of 41 trials over 17 years measured dietary intake, raising concerns about unmonitored nutrient deficiencies and long-term health risks from GLP-1 weight-loss drugs.
4 Articles
4 Articles
‘Blind Spot’: Alarm Sounded on Lack of Research into Side Effects of Weight-Loss Drugs
While weight-loss medications are often hailed as wonder drugs for improving the lives of people battling obesity, dietitians are increasingly concerned about the lack of research into long-term nutritional health impacts. At least half a million Australians are taking weight-loss drugs such as Ozempic and Mounjaro every month, with popularity continuing to increase despite a shortage of the drugs. Nutrition and dietetics professor Clare Collins…
'Blind spot': alarm sounded on weight-loss medications • The Western Weekender
While weight-loss medications are often hailed as wonder drugs for improving the lives of people battling obesity, dietitians are increasingly concerned about the lack of research into long-term nutritional health impacts. At least half a million Australians are taking weight-loss drugs such as Ozempic and Mounjaro every month, with popularity continuing to increase despite a shortage of the drugs. Nutrition and dietetics professor Clare Collins…
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium


